LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

BioResearch

Image An adeno-associated virus capsid (blue) modified by peptides (red) inserted to lock the virus is the result of research at Rice University into a new way to target cancerous and other diseased cells. The peptides are keyed to proteases overexpressed at the site of diseased tissues; they unlock the capsid and allow it to deliver its therapeutic cargo (Photo courtesy of Junghae Suh/Rice University).

Nanodelivery System Securely Targets Cancer cells

Scientists have devised a tunable virus that works similar to a safe deposit box. It takes two keys to open it and release its therapeutic payload.  More...
20 May 2014
Image: Left ventricular cardiac hypertrophy in short axis view (Photo courtesy of Patrick Lynch).

Possible Target for Gene Therapy May Correct Cardiac Hypertrophy

A deficit in the expression of the protein Erbin has been linked to the development of cardiac hypertrophy and heart failure.  More...
19 May 2014

Potential Drug Target Identified in Mouse Pancreatic Cancer Model

Cancer researchers studying pancreatic cancer have identified Yes-associated protein as a potential drug target whose inhibition would block the activity of the KRAS oncogene.  More...
19 May 2014

Canada to Establish “Big Data” Cloud-Computing Facility for Cancer Research

The Government of Canada announced CAD 7.3 million in funding for a collaboration—both in Canada and internationally—to develop tools that can effectively manipulate huge amounts of data to help find cures for cancer.   More...
19 May 2014
Image: Graphic of the malaria parasite Plasmodium in a red
blood cell (Photo courtesy of Simon Levey).

Novel Technique Allows Genome Sequencing of Single Malaria Cells

  More...
18 May 2014

Bioinformatics Application Designed to Look for New Uses for Old Drug

By tying together cancer gene expression patterns with drug activity, scientists have found a possible cancer therapy concealed within an antimicrobial agent.   More...
18 May 2014

Allergan Rejects Valeant Pharmaceuticals Takeover bid

Allergan, the manufacturer of Botox, has rejected a USD 46 billion unsolicited takeover bid made by Valeant Pharmaceuticals, on the basis that the proposal substantially undervalues the company.  More...
18 May 2014
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Thyroid Test
Anti-Thyroid EIA Test
New
Manual Pipetting Aid
Pipette Controllers macro


BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.
INTEGRA BIOSCIENCES AG